3,4-dihydroxyphenylacetic acid has been researched along with thiophenes in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Vries, JB; Santiago, M; Westerink, BH | 1 |
| Santiago, M; Westerink, BH | 3 |
| Aalto, J; Kiianmaa, K | 1 |
| De Vries, JB; Horn, AS; Tepper, PG; Timmerman, W; Westerink, BH | 1 |
| Dell, HD; Schöllnhammer, G; Seidel, PR | 1 |
| Engleman, EA; Mayle, DA; Perry, KW; Wong, DT | 1 |
| Jackson, M; Jenner, P; Treseder, SA | 1 |
| Andreassen, OA; Beal, MF; Ferrante, RJ; Klivenyi, P; Lancelot, E; Reif, D | 1 |
| Benvenga, MJ; Bymaster, FP; Calligaro, DO; Cohen, IR; Falcone, JF; Hemrick-Luecke, SK; Martin, FM; Moore, NA; Nelson, DL; Nisenbaum, LK; Rasmussen, K; Schaus, JM; Sundquist, SJ; Tupper, DE; Wiernicki, TR | 1 |
| Muneoka, K; Shioda, S; Shirayama, Y; Takigawa, M | 1 |
| Bencherif, M; Kucinski, A; Stachowiak, EK; Stachowiak, MK; Syposs, C; Wersinger, S | 1 |
| Boissonnet, A; Cloix, JF; Hévor, T; Landemarre, L | 1 |
| Evans, RM; Martin, HL; Mounsey, RB; Mustafa, S; Nelson, MC; Sathe, K; Teismann, P | 1 |
15 other study(ies) available for 3,4-dihydroxyphenylacetic acid and thiophenes
| Article | Year |
|---|---|
In vivo evidence for a concordant response of terminal and dendritic dopamine release during intranigral infusion of drugs.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bicuculline; Brain; Dopamine; Dopamine Agents; Male; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, N-Methyl-D-Aspartate; Sulpiride; Tetrahydronaphthalenes; Thiophenes | 1992 |
Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Butyrolactone; Animals; Consciousness; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Injections, Intraperitoneal; Male; Microchemistry; Nomifensine; Perfusion; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra; Sulpiride; Tetrahydronaphthalenes; Tetrodotoxin; Thiophenes | 1991 |
The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Consciousness; Corpus Striatum; Dendrites; Dopamine; Dopamine Agents; Dopamine Antagonists; Ergolines; Male; Neurons; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra; Sulpiride; Tetrahydronaphthalenes; Thiophenes | 1991 |
Role of adenylate cyclase in the modulation of the release of dopamine: a microdialysis study in the striatum of the rat.
Topics: 1-Methyl-3-isobutylxanthine; 3,4-Dihydroxyphenylacetic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Rats; Rats, Inbred Strains; Stereoisomerism; Sulpiride; Tetrahydronaphthalenes; Thiophenes | 1990 |
Role of brain monoaminergic systems in the increased ethanol drinking caused by REM-sleep deprivation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Animals; Brain Chemistry; Catecholamines; Citalopram; Dopamine; Hydroxyindoleacetic Acid; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Piperazines; Prazosin; Propylamines; Rats; Serotonin; Sleep Deprivation; Sleep, REM; Thiophenes | 1987 |
Microdialysis and striatal dopamine release: stereoselective actions of the enantiomers of N-0437.
Topics: 3,4-Dihydroxyphenylacetic Acid; Administration, Cutaneous; Administration, Oral; Animals; Brain Chemistry; Corpus Striatum; Dialysis; Dopamine; Dopamine Agents; Injections, Intraperitoneal; Kainic Acid; Male; Naphthalenes; Rats; Rats, Inbred Strains; Stereoisomerism; Sulpiride; Tetrahydronaphthalenes; Thiophenes | 1989 |
[Biochemical studies on tienocarbine and related compounds].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Binding, Competitive; Brain Chemistry; Catecholamines; Caudate Nucleus; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Indoles; Male; Norepinephrine; Putamen; Rats; Rats, Inbred Strains; Serotonin; Spiperone; Structure-Activity Relationship; Thiophenes | 1984 |
Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; Animals; Biogenic Monoamines; Blood Platelets; Dopamine; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Hypothalamus; In Vitro Techniques; Male; Microdialysis; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptosomes; Thiophenes | 1995 |
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Behavior, Animal; Callithrix; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Hydrazines; Levodopa; Male; Motor Activity; Quinolones; Quinpirole; Thiophenes; Tyrosine | 2000 |
Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoquinolines; Male; Mice; MPTP Poisoning; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Substantia Nigra; Tetrahydroisoquinolines; Thiophenes; Tyrosine 3-Monooxygenase | 2000 |
Preclinical pharmacology of FMPD [6-fluoro-10-[3-(2-methoxyethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene]: a potential novel antipsychotic with lower histamine H1 receptor affinity than olanzapine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzodiazepines; Body Weight; Catalepsy; Cocaine; Corticosterone; Drug Evaluation, Preclinical; Electrochemistry; Electrophysiology; Fasting; Female; Immunohistochemistry; Male; Molecular Structure; Motor Activity; Nucleus Accumbens; Olanzapine; Piperazines; Prolactin; Quipazine; Radioligand Assay; Rats; Rats, Inbred F344; Rats, Inbred Strains; Rats, Sprague-Dawley; Receptors, Histamine H1; Serotonin Receptor Agonists; Thiophenes; Time Factors | 2005 |
Brain region-specific effects of short-term treatment with duloxetine, venlafaxine, milnacipran and sertraline on monoamine metabolism in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Cyclohexanols; Cyclopropanes; Dopamine; Duloxetine Hydrochloride; Homovanillic Acid; Male; Milnacipran; Norepinephrine; Organ Specificity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Time Factors; Venlafaxine Hydrochloride | 2009 |
α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdialysis; Neural Inhibition; Nicotinic Agonists; Quinuclidines; Receptor, Fibroblast Growth Factor, Type 1; Reflex, Startle; Schizophrenia; Sensory Gating; Thiophenes | 2012 |
Monoamines and glycogen levels in cerebral cortices of fast and slow methionine sulfoximine-inbred mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Disease Models, Animal; Glycogen; Hydroxyindoleacetic Acid; Methionine Sulfoximine; Mice; Mice, Inbred Strains; Seizures; Serotonin; Thiophenes | 2013 |
A peroxisome proliferator-activated receptor-δ agonist provides neuroprotection in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Count; Cells, Cultured; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Female; Glial Fibrillary Acidic Protein; Humans; Macrophage-1 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Parkinsonian Disorders; PPAR delta; Rats; Sulfones; Thiazoles; Thiophenes; Tyrosine 3-Monooxygenase | 2013 |